A color segmentation-based method to quantify atherosclerotic lesion compositions with immunostaining

Methods in Molecular Biology

Volumn 1614, Issue , 2017, Pages 21-30

  Wu, Congqing ^a   Daugherty, Alan ^a   Lu, Hong ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Antibody; Atherosclerosis; Color; Imaging; Immunostaining

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; BIOLOGICAL MARKER; LOW DENSITY LIPOPROTEIN RECEPTOR;

ATHEROSCLEROSIS; COLOR; IMMUNOHISTOCHEMISTRY; JUXTAGLOMERULAR CELL; KIDNEY PROXIMAL TUBULE; NONHUMAN; ANIMAL; AUTOMATED PATTERN RECOGNITION; COMPUTER ASSISTED DIAGNOSIS; DISEASE MODEL; ENZYME IMMUNOASSAY; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; PHYSIOLOGY; PROCEDURES; STAINING;

ANIMALS; ATHEROSCLEROSIS; BIOMARKERS; DISEASE MODELS, ANIMAL; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; MALE; MICE; MICE, KNOCKOUT; PATTERN RECOGNITION, AUTOMATED; RECEPTORS, LDL; STAINING AND LABELING;

EID: 85019269827     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-7030-8_2     Document Type: Chapter

References (29)

1. Breslow JL (1996) Mouse models of atherosclerosis. Science 272:685-688
2. Ishibashi S, Goldstein JL, Brown MS, Herz J, Burns DK (1994) Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest 93:1885-1893
3. Plump AS, Smith JD, Hayek T, Aaltosetala K, Walsh A, Verstuyft JG et al (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein-E-deficient mice created by homologous recombination in ES cells. Cell 71:343-353
4. Zhang SH, Reddick RL, Piedrahita JA, Maeda N (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258:468-471
5. Daugherty A, Manning MW, Cassis LA (2000) Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105:1605-1612
6. Daugherty A, Rateri DL, Lu H, Inagami T, Cassis LA (2004) Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation 110:3849-3857
7. Wassmann S, Czech T, van Eickels M, Fleming I, Bohm M, Nickenig G (2004) Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice. Circulation 110:3062-3067
8. Lu H, Rateri DL, Feldman DL, Charnigo RJ Jr, Fukamizu A, Ishida J et al (2008) Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice. J Clin Invest 118:984-993
9. Daugherty A, Lu H, Rateri DL, Cassis LA (2008) Augmentation of the renin-angiotensin system by hypercholesterolemia promotes vascular diseases. Future Lipidol 3:625-636
10. Lu H, Balakrishnan A, Howatt DA, Wu C, Charnigo R, Liau G et al (2012) Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis. Br J Pharmacol 165:2000-2008
11. Chen XC, Lu H, Zhao M, Tashiro K, Cassis LA, Daugherty A (2013) Angiotensin-converting enzyme promotes atherosclerosis through an angiotensin I to angiotensin II pathway involving leukocytes. Arterioscler Thromb Vasc Biol 33:2075-2080
12. Lu H, Wu C, Howatt DA, Balakrishnan A, Moorleghen JJ, Chen X et al (2016) Angiotensinogen exerts effects independent of angiotensin II. Arterioscler Thromb Vasc Biol 36:256-265
13. Daugherty A, Cassis L (1999) Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -/- mice. Ann N Y Acad Sci 892:108-118
14. Weiss D, Kools JJ, Taylor WR (2001) Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoEdeficient mice. Circulation 103:448-454
15. Imanishi T, Tsujioka H, Ikejima H, Kuroi A, Takarada S, Kitabata H et al (2008) Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes. Hypertension 52:563-572
16. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G (2000) Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N Engl J Med 342:145-153
17. ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, Dyal L, Copland I et al (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358:1547-1559
18. Lu H, Rateri DL, Daugherty A (2007) Immunostaining of mouse atherosclerosis lesions. Methods Mol Med 139:77-94
19. Wu C, Xu Y, Lu H, Howatt DA, Balakrishnan A, Moorleghen JJ et al (2015) Cys18-Cys137 disulfide bond in mouse angiotensinogen does not affect AngII-dependent functions in vivo. Hypertension 65:800-805
20. Yiannikouris F, Wang Y, Shoemaker R, Larian N, Thompson J, English VL et al (2015) Deficiency of angiotensinogen in hepatocytes markedly decreases blood pressure in lean and obese male mice. Hypertension 66:836-842
21. Wu C, Lu H, Cassis LA, Daugherty A (2011) Molecular and pathophysiological features of angiotensinogen: a mini review. N Am J Med Sci (Boston) 4:183-190
22. Matsusaka T, Niimura F, Shimizu A, Pastan I, Saito A, Kobori H et al (2012) Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol 23:1181-1189
23. Chen XC, Howatt DA, Balakrishnan A, Moorleghen JJ, Wu CQ, Cassis LA et al (2016) Angiotensin-converting enzyme in smooth muscle cells promotes atherosclerosis. Arterioscler Thromb Vasc Biol 36:1085-1089
24. Benicky J, Hafko R, Sanchez-Lemus E, Aguilera G, Saavedra JM (2012) Six commercially available angiotensin II AT(1) receptor antibodies are nonspecific. Cell Mol Neurobiol 32:1353-1365
25. Herrera M, Sparks MA, Alfonso-Pecchio AR, Harrison-Bernard LM, Coffman TM (2013) Response to lack of specificity of commercial antibodies leads to misidentification of angiotensin type-1 receptor protein. Hypertension 61:e32
26. Zhang G, Chen Y, BilalWaqar A, Han L, Jia M, Xu C et al (2015) Quantitative analysis of rabbit coronary atherosclerosis. Practical techniques utilizing open-source software. Anal Quant Cytol Histol 37:115-122
27. Vrekoussis T, Chaniotis V, Navrozoglou I, Dousias V, Pavlakis K, Stathopoulos EN et al (2009) Image analysis of breast cancer immunohistochemistry-stained sections using ImageJ: an RGB-based model. Anticancer Res 29:4995-4998
28. Daugherty A, Whitman SC (2003) Quantification of atherosclerosis in mice. Methods Mol Biol 209:293-309
29. Daugherty A, Lu H, Howatt DA, Rateri DL (2009) Modes of defining atherosclerosis in mouse models: relative merits and evolving standards. Methods Mol Biol 573:1-15